← Back to Clinical Trials
Recruiting NCT04349475

NCT04349475 Therapeutic Omegas for Triglyceride Suppression

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT04349475
Status Recruiting
Phase
Sponsor University of Colorado, Denver
Condition Pregnancy
Study Type INTERVENTIONAL
Enrollment 40 participants
Start Date 2021-11-29
Primary Completion 2025-12-01

Trial Parameters

Condition Pregnancy
Sponsor University of Colorado, Denver
Study Type INTERVENTIONAL
Phase N/A
Enrollment 40
Sex ALL
Min Age 0 Years
Max Age 39 Years
Start Date 2021-11-29
Completion 2025-12-01
Interventions
Intervention Omega 3 SupplementationControl Safflower Oil

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This study plans to learn more about how an omega-3 fatty acid supplement effects triglyceride levels in pregnancy. Triglycerides are a type of fat found in your blood. Your body converts extra calories into triglycerides to be stored and used later for energy. It is normal for triglyceride levels to go up during pregnancy however some women have levels that are \~30-40% higher than normal when they reach their third trimester of pregnancy. Having high triglycerides in pregnancy may be related to an increased chance of having a baby that is large for their age. The goal of this study is to determine if taking an omega-3 fatty acid supplement can slow the rise in triglyceride levels later in pregnancy.

Eligibility Criteria

Inclusion Criteria: * Pregnant women between the ages of 21-39 yrs * Pre-pregnancy BMI 28-39 * Fasting Triglyceride ≥120 mg/dL measured by 15 wks Exclusion Criteria: * Pre-gestational diabetes or prediabetes * History of gestational diabetes, * History of pre-eclampsia, spontaneous pre-term delivery, or gestational hypertension \<34wks * Tobacco or illicit substance use * Chronic steroid use

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology